SmithKline says profits rose 10%
Article Abstract:
SmithKline Beecham Corp. posted a 10% increase in pretax profits. The British company, whose US headquarters is in Philadelphia, said its merger with Glaxo Wellcome PLC is on track for summer 2000.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Inquiry by FTC delays merger; SmithKline Beecham and Glaxo Wellcome planned to unite Spet. 25
Article Abstract:
SmithKline Beecham P.L.C., whose U.S. headquarters are in Philadelphia, and Glaxo Wellcome P.L.C. have again delayed their $70 million merger, but have set a new date for the end of this year. The merger was delayed because of a Federal Trade Commission request for additional information about the companies' smoking cessation products.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Big drug merger will be delayed
Article Abstract:
The article discusses the rescheduling of the proposed merger of SmithKline Beecham P.L.C. and Glaxo Wellcome P.L.C. The merger was rescheduled from 8/21 to 9/21 because of delays in getting federal and foreign antitrust approvals.
Publication Name: Philadelphia Inquirer (PA)
Subject: Business, regional
ISSN: 0885-6613
Year: 2000
User Contributions:
Comment about this article or add new information about this topic: